Loomis Sayles & CO L P Enanta Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$85.46 - $126.37 $7,691 - $11,373	-90 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$57.91 - $92.15 $35,730 - $56,856	-617 Reduced 87.27%	90 $7,000
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $958 - $1,246	21 Added 3.06%	707 $41,000
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $1,933 - $2,386	51 Added 8.03%	686 $32,000
Q2 2017 Aug 14, 2017	BUY	N/A	635	635 $23,000

108

21.7M

9.4K

3.3K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $279M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.